Bicycle Therapeutics has developed a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle) product platform, and will gain funding for phase 1 and phase 1b clinical trial ...

Department of Chemistry, Stanford University, 337 Campus Drive, Stanford, California 94305, United States ...